Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Technical Report
  • Published:

High-throughput and high-dimensional single-cell analysis of antigen-specific CD8+ T cells

Abstract

Although critical to T cell function, antigen specificity is often omitted in high-throughput multiomics-based T cell profiling due to technical challenges. We describe a high-dimensional, tetramer-associated T cell antigen receptor (TCR) sequencing (TetTCR-SeqHD) method to simultaneously profile cognate antigen specificities, TCR sequences, targeted gene expression and surface-protein expression from tens of thousands of single cells. Using human polyclonal CD8+ T cells with known antigen specificity and TCR sequences, we demonstrate over 98% precision for detecting the correct antigen specificity. We also evaluate gene expression and phenotypic differences among antigen-specific CD8+ T cells and characterize phenotype signatures of influenza- and Epstein–Barr virus-specific CD8+ T cells that are unique to their pathogen targets. Moreover, with the high-throughput capacity of profiling hundreds of antigens simultaneously, we apply TetTCR-SeqHD to identify antigens that preferentially enrich cognate CD8+ T cells in patients with type 1 diabetes compared to healthy controls and discover a TCR that cross-reacts with diabetes-related and microbiome antigens. TetTCR-SeqHD is a powerful approach for profiling T cell responses in humans and mice.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Schematics of the TetTCR-SeqHD workflow.
Fig. 2: TetTCR-SeqHD validation in cultured human polyclonal CD8+ T cells.
Fig. 3: TetTCR-SeqHD enables combined gene expression, phenotype and TCR clonality comparison among antigen-specific CD8+ T cells.
Fig. 4: Gene expression and phenotype analysis of foreign antigen-specific T cells and cross-reactivity validation.
Fig. 5: Identification of three T cell specificities selectively enriched in patients with T1D and TCR specificity and cross-reactivity validation.

Similar content being viewed by others

Data availability

All TCR and peptide information is in the supplementary tables. The accession number for raw sequencing data is phs002441.v1.p1 on dbGaP. Source data are provided with this paper.

Code availability

Custom analysis code is available on GitHub (https://github.com/JiangLabSysImmune).

References

  1. Davis, M. M. & Boyd, S. D. Recent progress in the analysis of alphabetaT cell and B cell receptor repertoires. Curr. Opin. Immunol. 59, 109–114 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Pulendran, B. & Davis, M. M. The science and medicine of human immunology. Science 369, 1582–1593 (2020).

    Article  Google Scholar 

  3. Satpathy, A. T. et al. Transcript-indexed ATAC-seq for precision immune profiling. Nat. Med. 24, 580–590 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Stoeckius, M. et al. Simultaneous epitope and transcriptome measurement in single cells. Nat. Methods 14, 865–868 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Peterson, V. M. et al. Multiplexed quantification of proteins and transcripts in single cells. Nat. Biotechnol. 35, 936–939 (2017).

    Article  CAS  PubMed  Google Scholar 

  6. Mair, F. et al. A targeted multi-omic analysis approach measures protein expression and low-abundance transcripts on the single-cell level. Cell Rep. 31, 107499 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Granja, J. M. et al. Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemia. Nat. Biotechnol. 37, 1458–1465 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Fernandez, D. M. et al. Single-cell immune landscape of human atherosclerotic plaques. Nat. Med. 25, 1576–1588 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Su, Y. et al. Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19. Cell 183, 1479–1495 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Li, G. et al. T cell antigen discovery via trogocytosis. Nat. Methods 16, 183–190 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Joglekar, A. V. et al. T cell antigen discovery via signaling and antigen-presenting bifunctional receptors. Nat. Methods 16, 191–198 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kisielow, J., Obermair, F. J. & Kopf, M. Deciphering CD4+ T cell specificity using novel MHC-TCR chimeric receptors. Nat. Immunol. 20, 652–662 (2019).

    Article  CAS  PubMed  Google Scholar 

  13. Kula, T. et al. T-scan: a genome-wide method for the systematic discovery of T cell epitopes. Cell 178, 1016–1028 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Sharma, G., Rive, C. M. & Holt, R. A. Rapid selection and identification of functional CD8+ T cell epitopes from large peptide-coding libraries. Nat. Commun. 10, 4553 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  15. Ferretti, A. P. et al. Unbiased screens show CD8+ T cells of COVID-19 patients recognize shared epitopes in SARS-CoV-2 that largely reside outside the spike protein. Immunity 53, 1095–1107 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Newell, E. W. et al. Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization. Nat. Biotechnol. 31, 623–629 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Simoni, Y. et al. Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates. Nature 557, 575–579 (2018).

    Article  CAS  PubMed  Google Scholar 

  18. Zhang, S. Q. et al. High-throughput determination of the antigen specificities of T cell receptors in single cells. Nat. Biotechnol. 36, 1156–1159 (2018).

    Article  CAS  Google Scholar 

  19. Rodenko, B. et al. Generation of peptide-MHC class I complexes through UV-mediated ligand exchange. Nat. Protoc. 1, 1120–1132 (2006).

    Article  CAS  PubMed  Google Scholar 

  20. Bender, C., Rajendran, S. & von Herrath, M. G. New insights into the role of autoreactive CD8 T cells and cytokines in human type 1 diabetes. Front Endocrinol. (Lausanne) 11, 606434 (2020).

    Article  Google Scholar 

  21. Shahi, P., Kim, S. C., Haliburton, J. R., Gartner, Z. J. & Abate, A. R. Abseq: Ultrahigh-throughput single cell protein profiling with droplet microfluidic barcoding. Sci. Rep. 7, 44447 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Ma, K. Y. et al. Immune repertoire sequencing using molecular identifiers enables accurate clonality discovery and clone size quantification. Front. Immunol. 9, 33 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  23. Gayoso, A. et al. Joint probabilistic modeling of single-cell multi-omic data with totalVI. Nat. Methods 18, 272–282 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. McInnes, L., Healy, J. & Melville, J. Umap: uniform manifold approximation and projection for dimension reduction. Preprint at https://arxiv.org/abs/1802.03426 (2018).

  25. Levine, J. H. et al. Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis. Cell 162, 184–197 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Pita-Lopez, M. L., Pera, A. & Solana, R. Adaptive memory of human NK-like CD8+ T-cells to aging, and viral and tumor antigens. Front. Immunol. 7, 616 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  27. Keating, R. et al. Potential killers exposed: tracking endogenous influenza-specific CD8+ T cells. Immunol. Cell Biol. 96, 1104–1119 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Sharma, S. et al. T cell immunoglobulin and mucin protein-3 (Tim-3)/galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses. Proc. Natl Acad. Sci. USA 108, 19001–19006 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Ibegbu, C. C. et al. Differential expression of CD26 on virus-specific CD8+ T cells during active, latent and resolved infection. Immunology 126, 346–353 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Men, Y. et al. Assessment of immunogenicity of human Melan-A peptide analogues in HLA-A*0201/Kb transgenic mice. J. Immunol. 162, 3566–3573 (1999).

    Article  CAS  PubMed  Google Scholar 

  31. Derre, L. et al. A novel population of human melanoma-specific CD8 T cells recognizes Melan-AMART-1 immunodominant nonapeptide but not the corresponding decapeptide. J. Immunol. 179, 7635–7645 (2007).

    Article  CAS  PubMed  Google Scholar 

  32. Dutoit, V. et al. Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-a peptide multimer+ CD8+ T cells in humans. J. Exp. Med. 196, 207–216 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Blancou, P. et al. Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patients. J. Immunol. 178, 7458–7466 (2007).

    Article  CAS  PubMed  Google Scholar 

  34. Abreu, J. R. et al. CD8 T cell autoreactivity to preproinsulin epitopes with very low human leucocyte antigen class I binding affinity. Clin. Exp. Immunol. 170, 57–65 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Kracht, M. J. et al. Autoimmunity against a defective ribosomal insulin gene product in type 1 diabetes. Nat. Med. 23, 501–507 (2017).

    Article  CAS  PubMed  Google Scholar 

  36. Cole, D. K. et al. Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity. J. Clin. Invest. 126, 3626 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  37. Velthuis, J. H. et al. Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers. Diabetes 59, 1721–1730 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Wiedeman, A. E. et al. Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progression. J. Clin. Invest. 130, 480–490 (2020).

    Article  CAS  PubMed  Google Scholar 

  39. Culina, S. et al. Islet-reactive CD8+ T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors. Sci. Immunol. 3, 20 (2018).

    Article  Google Scholar 

  40. Shum, E. Y., Walczak, E. M., Chang, C. & Fan, H. C. in Single Molecule and Single Cell Sequencing (ed. Suzuki, Y.) 63–79 (Springer Singapore, 2019).

  41. Yu, W. et al. Clonal deletion prunes but does not eliminate self-specific alphabeta CD8(+) T lymphocytes. Immunity 42, 929–941 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Smith, T., Heger, A. & Sudbery, I. UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy. Genome Res 27, 491–499 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Wendel, B. S. et al. Accurate immune repertoire sequencing reveals malaria infection driven antibody lineage diversification in young children. Nat. Commun. 8, 531 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  45. Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  46. Jurtz, V. et al. NetMHCpan-4.0: improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data. J. Immunol. 199, 3360–3368 (2017).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank the patients with T1D for donating blood samples to our study. We also thank anonymous blood donors and staff members at We Are Blood for sample collection. We thank P. Parker for assistance with blood sample purification. We thank S. Chizari for assistance with uploading sequencing data to dbGaP and source code to GitHub. This work was supported by National Institutes of Health grants S10OD020072 (N.J.), R33CA225539 (N.J.) and R56AG064801 (N.J.); National Science Foundation CAREER award 1653866 (N.J.); Welch Foundation grant F1785 (N.J.); the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation (N.J.); and the Chan Zuckerberg Initiative Neurodegeneration Challenge Network Ben Barres Early Career Acceleration Awards 191856 (N.J.). We would also like to acknowledge funding from the University of Texas at Austin Cockrell School of Engineering Fellowship (A.A.S.), Mario E. Ramirez Endowed Graduate Fellowship (A.A.S.) and the Harry and Rubye Gaston Graduate Scholarship (A.A.S.).

Author information

Authors and Affiliations

Authors

Contributions

K.-Y.M. and N.J. conceived and designed the study. K.-Y.M. designed and developed the technology platform; K.-Y.M. and A.A.S. performed and analyzed data for the majority of experiments; K.-Y.M. developed the pipeline to analyze tetramer DNA-barcode data; C.H. and K.-Y.M. developed the script for analyzing TCR sequence data; A.A.S., A.X., E.C., and Y.W.G. performed TCR transduction experiments; E.S. performed in vitro cell culture; A.A.S. and Y.W.G. performed tetramer staining and CD107α experiments. K.R.S. and M.K.-D. recruited patients with T1D and collected blood samples from them. R.B. provided help with Rhapsody-related experiments; K.-Y.M. and N.J. wrote the manuscript with help from all co-authors.

Corresponding author

Correspondence to Ning Jiang.

Ethics declarations

Competing interests

N.J. is a scientific advisor and holds equity interest in ImmuDX and Immune Arch, companies that are developing products related to the research reported. R.B. is an employee of Becton Dickinson, which provided some of the equipment and reagents used in the study. The remaining authors declare no competing interests.

Additional information

Peer review information Nature Immunology thanks Iwijn De Vlaminck, Angela Wu, and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. L. A. Dempsey was the primary editor on this article and managed its editorial process and peer review in collaboration with the rest of the editorial team.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Extended data

Extended Data Fig. 1 Tetramer-positive CD8+ T cells from a mixture of pMHC tetramer-sorted polyclonal T cells cultured in vitro and quality check of gene expression.

a, Gating strategy for sorting tetramer-positive CD8+ T cells from a mixture of pMHC tetramer sorted polyclonal T cells cultured in vitro. b,c, Distribution of mRNA counts (log10) (b) and number of detected genes per cell (c) among different antigen-specific T cell populations. Horizontal lines represent 25th percentile, median and 75th percentile values, with whiskers extending to the farthest data point within a maximum of 1.5 × interquartile range.

Source data

Extended Data Fig. 2 Absolute expression (log10 of MID counts) of differentially expressed genes and surface proteins among different clusters.

a,b, Genes and surface protein plotted here are the same set as in Fig. 3d. c, Distributions of AbSeq MID counts for differentially expressed surface proteins shown in Fig. 3d. d, Density plot showing of all CD8 T cells by AbSeq MID counts of CD45RA vs. CD197, and CD28 vs. CD27, respectively. Colors represent the local density of cells on the two-dimensional space.

Source data

Extended Data Fig. 3 TetTCR-SeqHD enables combined gene expression, phenotype and TCR clonality comparison among antigen-specific CD8+ T cells.

a, UMAP of single cells among different donors. Grey dots represent all cells and colored dots are cells from different chips. b, Comparison of the distribution of phenotypes between tetramer-positive and tetramer-negative CD8+ T cells. c, Percentage of naive population in each antigen-specific CD8+ T cell group. d, Percentage breakdown of naive CD8+ T cells among all major antigen specificities. Only antigen specificities with a percentage greater than 1% within the naive population are shown. ‘NEG’ cells are tetramer-negative CD8+ T cells identified by tetramer MID counts. Cells were classified into filter category based on the following criteria: (1) more than one antigen binds to a single cell, and these antigens are a distance of more than 3 amino acids away from each other; (2) correlation of tetramer MID between single cells and the median of all cells with same TCR sequence is below 0.9, identified as described in Methods.

Source data

Extended Data Fig. 4 Distribution of representative tetramer MID counts.

a, Distribution of tetramer MID counts for eight antigen specificities, including EBV antigens (EBV-BLMF1, BZLF1-190-197, EBV-BRLF1 and EBV-LMP2A), influenza viral antigens (M1 and NP44-52), T1D-associated antigens (PTPRN-FGD-9 and ZNT8-115-123) or cross-reactive antigens (HCV, Mart1 and DUF5119-124-133/INSDRIP-1-9/PTPRN-797-805). For each cell in the group, the MID counts for each of the 280 antigens used in the experiment were tallied and then overlaid in the same order of the 280 antigens. Only the antigens that emerge after the filter are labeled on the x axis, and their position in the 280 antigen list is indicated by a tick on the x axis. Each panel with a sharp single peak indicated single antigen specificity, while panels with multiple sharp peaks indicated cross-reactive antigens. b, Comparison of tetramer MID counts among DUF5119-124-133/INSDRIP-1-9/PTPRN-797-805 cross-reactive and single antigen-specific cells.

Source data

Extended Data Fig. 5 Analysis of T cells with bound antigen specificity being mismatched HLA alleles.

a, Summary of percentage of antigen-specific T cells with mismatched HLA alleles in all donors. Combined percentages from two sources are presented (Discussion). b, Percentage of antigen-specific T cells with mismatched HLA alleles in each donor. Combined percentages of two sources are presented (Discussion). c, Comparison of phenotypes of cells with mismatched HLA alleles with the overall population. Gray dots represent all CD8+ T cells.

Source data

Extended Data Fig. 6 Distribution of viral antigen-specific CD8+ T cells among 12 primary CD8+ T cells clusters in all 18 donors when the tetramer-negative MID threshold was set to 15.

Distribution of viral antigen-specific CD8+ T cells among 12 primary CD8+ T cells clusters in all 18 donors when the tetramer-negative MID threshold was set to 15 (Methods).

Source data

Extended Data Fig. 7 Frequency of total T1D autoantigen-specific CD8+ T cells in healthy subjects and T1D patients.

a, Frequency of T1D autoantigen tetramer-positive CD8+ T cells in different donors for various HLA alleles. b, Comparison of total T1D autoantigen tetramer-positive CD8+ T cells between healthy and T1D donors for various HLA alleles. A two-sided Wilcoxon nonparametric test was performed. Horizontal lines represent 25th percentile, median and 75th percentile values, with whiskers extending to the farthest data point within a maximum of 1.5 × interquartile range. The number of subjects with HLA-A01:01, A02:01 and B08:01 are 10, 12 and 10, respectively.

Source data

Extended Data Fig. 8 T1D autoantigens with different antigen-specific CD8+ T cell frequencies and clonality between healthy subjects and T1D patients.

a, Five T1D autoantigens were identified to have a significantly higher frequency of antigen-specific T cells in peripheral blood when the MID-negative threshold was set to 15. A two-sided Wilcoxon nonparametric test was performed. Horizontal lines represent 25th percentile, median and 75th percentile values, with whiskers extending to the farthest data point within a maximum of 1.5 × interquartile range. The number of subjects with HLA-A01:01, A02:01 and B08:01 are 10, 12 and 10, respectively. b, TCR clonality heatmap of T1D antigenic-specific T cells for each antigen/donor combination. Grey, no T cells were detected.

Source data

Extended Data Fig. 9 Comparison of T1D antigen-specific CD8+ T cells between T1D patients and healthy subjects.

a, UMAP of T1D antigen-specific CD8+ T cells in T1D patients and healthy subjects respectively. Colored dots are T1D antigen-specific CD8+ T cells, and gray dots are other cells. b, Comparison of the distribution of phenotypes among T1D antigen-specific CD8+ T cells in each donor. Wilcoxon test was performed, with no significance between T1D and healthy subjects in any cluster.

Source data

Extended Data Fig. 10 TCR specificity and cross-reactivity validation by tetramer staining.

Bar plot showing the percentage of tetramer-positive cells gated on TCRβhi fraction of the cells, corresponding to Fig. 5b. Tetramer staining experiments were performed in triplicate. A two-tailed Student’s t test was performed between cognate tetramer and each negative control for all TCRs. EBV-BLMF1: GLCTLVAML; INSDRIP-1-9: MLYQHLLPL; DUF5119-124-133: MVWGPDPLYV; PTPRN-797-805: MVWESGCTV; PTPRN-FGD-9: FGDHPGHSY; INS-WMR-8: WMRLLPLL. ns, not significant; *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001.

Source data

Supplementary information

Supplementary Information

Supplementary Figures 1-8

Reporting Summary

Peer Review Information

41590_2021_1073_MOESM4_ESM.xlsx

Supplementary Table 1: Antigens used to sort and stimulate polyclonal CD8+ T cells. Supplementary Table 2: Sequencing metrics for all TetTCR-SeqHD experiments. Supplementary Table 3: Reference sequences of TCRβ for polyclonal CD8+ T cells. Supplementary Table 4: Endogenous and foreign antigens used in TetTCR-SeqHD experiments with primary CD8+ T cells. Supplementary Table 5: Healthy individuals without T1D and patients with T1D and T2D used in the TetTCR-SeqHD experiments. Supplementary Table 6: Number of antigens and cells detected for non-T1D endogenous, T1D, and viral antigens in each individual. Supplementary Table 7: Summary of transduced TCR sequences and their cognate antigen specificities. Supplementary Table 8: Oligonucleotide sequences used in TetTCR-SeqHD. Supplementary Table 9: Oligonucleotides used to label additional antibodies.

Source data

Source Data Fig. 2

Statistical source data.

Source Data Fig. 3

Statistical source data.

Source Data Fig. 4

Statistical source data.

Source Data Fig. 5

Statistical source data.

Source Data Extended Data Fig. 1

Statistical source data.

Source Data Extended Data Fig. 2

Statistical source data.

Source Data Extended Data Fig. 3

Statistical source data.

Source Data Extended Data Fig. 4

Statistical source data.

Source Data Extended Data Fig. 5

Statistical source data.

Source Data Extended Data Fig. 6

Statistical source data.

Source Data Extended Data Fig. 7

Statistical source data.

Source Data Extended Data Fig. 8

Statistical source data.

Source Data Extended Data Fig. 9

Statistical source data.

Source Data Extended Data Fig. 10

Statistical source data.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ma, KY., Schonnesen, A.A., He, C. et al. High-throughput and high-dimensional single-cell analysis of antigen-specific CD8+ T cells. Nat Immunol 22, 1590–1598 (2021). https://doi.org/10.1038/s41590-021-01073-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41590-021-01073-2

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing